Metabolic reprogramming in IPF

R. Chambers (London, United Kingdom)

Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Number: 10
Disease area: Interstitial lung diseases

PDF journal article, handout or slidesSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Chambers (London, United Kingdom). Metabolic reprogramming in IPF. ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Metabolic changes in lung ageing and COPD
Source: International Congress 2019 – Metabolic alterations in lung ageing and disease
Year: 2019


Metabolic reprogramming and the risk of lung cancer
Source: International Congress 2017 – Metabolism in respiratory diseases: time for a rethink
Year: 2017


Reprogramming of cellular metabolism: driver for airway remodelling in COPD?
Source: Eur Respir J, 50 (5) 1702197; 10.1183/13993003.02197-2017
Year: 2017



Metabolic profiling in pulmonary diseases
Source: International Congress 2019 – Metabolic alterations in lung ageing and disease
Year: 2019


Metabolic syndrome and COPD
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010


Epigenetic control of TGFß induced fibrosis in COPD
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017

Targeting the epigenome in asthma and COPD
Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD
Year: 2013


Defective metabolic adaptation in the pathogenesis of COPD
Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease
Year: 2019


Metabolic regulation during the co-existence of COPD and DM type2
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


microRNA profiling in pulmonary fibroblasts in COPD
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011

Role of exosomal microRNA in driving skeletal muscle wasting in COPD
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015


Premature ageing in IPF
Source: Annual Congress 2012 - Searching for the secrets of senescence in the lung
Year: 2012


Connected systems in aging and IPF
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016


Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair
Source: ERS Lung Science Conference 2020
Year: 2020


Functional and molecular disparities between mesenchymal stem cells from various pulmonary disorders
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014



Profiling of COPD and IPF cytokine responses in human lung
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Transcriptomic and epigenetic changes in the lung of patients with severe COPD
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017